Milestone Total Stockholder Equity from 2010 to 2025
| MIST Stock | USD 1.98 0.02 1.02% |
Total Stockholder Equity | First Reported 2018-03-31 | Previous Quarter 32 M | Current Value 24 M | Quarterly Volatility 60.9 M |
Check Milestone Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Milestone Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.2 M or Interest Income of 4.2 M, as well as many indicators such as Price To Sales Ratio of 32.97, Dividend Yield of 0.0 or PTB Ratio of 4.04. Milestone financial statements analysis is a perfect complement when working with Milestone Pharmaceuticals Valuation or Volatility modules.
Milestone | Total Stockholder Equity |
Latest Milestone Pharmaceuticals' Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of Milestone Pharmaceuticals over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Milestone Pharmaceuticals' Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Milestone Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
Milestone Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 10,700,123 | |
| Coefficient Of Variation | 599.63 | |
| Mean Deviation | 52,057,888 | |
| Median | (33,119,000) | |
| Standard Deviation | 64,161,223 | |
| Sample Variance | 4116.7T | |
| Range | 198.3M | |
| R-Value | 0.57 | |
| Mean Square Error | 2979.5T | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | 7,676,656 | |
| Total Sum of Squares | 61749.9T |
Milestone Total Stockholder Equity History
About Milestone Pharmaceuticals Financial Statements
Milestone Pharmaceuticals shareholders use historical fundamental indicators, such as Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Milestone Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Milestone Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Milestone Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | 19.3 M | 18.3 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.